NivolumabMyasthenia gravis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1672卷 / 1期

关键词：

D O I：

10.1007/s40278-017-37019-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：202 / 202

相关论文

共 50 条

[31] NivolumabMyasthenia gravis Lambert-Eaton overlap syndrome: case report
Reactions Weekly, 2022, 1888 (1) : 287 - 287
[32] Ipilimumab/nivolumabMyasthenia gravis-like syndrome and haemorrhagic gastritis: case report
Reactions Weekly, 2020, 1793 (1) : 255 - 255
[33] Cemiplimab/nivolumabMyasthenia gravis and ocular myasthenia: 2 case reports
Reactions Weekly, 2022, 1888 (1) : 120 - 120
[34] Ipilimumab/nivolumabMyasthenia gravis with cardiac involvement, and axonal polyradiculoneuropathy with myocarditis: 3 case reports
Reactions Weekly, 2021, 1869 (1) : 194 - 194
[35] NivolumabMyasthenia gravis, rheumatoid arthritis and fulminant type 1 diabetes mellitus: 2 case reports
Reactions Weekly, 2017, 1682 (1) : 234 - 234
[36] SotalolMyasthenia gravis: case report
Reactions Weekly, 2019, 1778 (1) : 421 - 421
[37] NivolumabMyasthaenia gravis: case report
Reactions Weekly, 2019, 1773 (1) : 257 - 257
[38] RegorafenibMyasthenia gravis: case report
Reactions Weekly, 2023, 1953 (1) : 350 - 350
[39] PembrolizumabMyasthenia gravis: case report
Reactions Weekly, 2018, 1694 (1) : 353 - 353
[40] HydroxychloroquineMyasthenia gravis: case report
Reactions Weekly, 2019, 1737 (1) : 152 - 152

← 1 2 3 4 5 →